Animal Model: 6- to 9-week-old C57BL/6J male wild-type mice[1]
Dosage: 100, 250, 500 mg/KG in sterile 0.9% NaCl
Administration: p.o. for 35 days
Result: Inhibited tissue uptake of d3-creatine in a dose-dependent manner by up to 75% at 500 mg/kg.
参考文献
[1]. Kurth I, et al. Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Sci Adv. 2021 Oct 8;7(41):eabi7511.